Maynard Um
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX) Post Q1 Print
-
-
-
-
-
-
-
These are the best biotech stocks to own in 2026: BofA
-
-
-
-
-
-
-
RBC Capital on Vertex (VRTX): 'Recent Weakness Creates Buying Opportunity'
-
-
-
-
-
-
-
Jefferies Starts Amgen (AMGN) at Hold
-
-
-
-
-
-
-
After-hours movers: Hewlett Packard Enterprise, Yext, Vertex Pharma
-
-
-
-
-
-
-
Vertex (VRTX) PT Raised to $530 at Evercore ISI
-
-
-
-
-
-
-
BofA: 'our Top 10 Ideas include nine Buys and one Underperform across nine industries'
-
401,975 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

